TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
77 hedge funds and large institutions have $262M invested in Taro Pharmaceutical Industries Ltd. in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $548K
Holders
77
Holding in Top 10
1
Calls
–
Puts
$548K
Top Buyers
| 1 | +$3.34M | |
| 2 | +$2.01M | |
| 3 | +$1.92M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.19M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$930K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.84M | |
| 3 | -$1.4M | |
| 4 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
-$1.06M |
| 5 |
Bank of New York Mellon
New York
|
-$1.03M |